Samsung debuts a ‘smart ring’ with health-tracking features — its first foray into the product category

The Samsung Galaxy Ring has various sensors to track things like heart rate. Samsung BARCELONA, Spain…

New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle

Blood sample of patient positive tested for sickle cell. Kitsawet Saethao | Istock | Getty Images…

Nearly all doctors feel burnout, but many are encouraged by potential of AI, survey says

Suriyapong Thongsawang | Moment | Getty Images Doctors in the U.S. are struggling to contend with…

Healthy Returns: Novo Nordisk, Eli Lilly are tackling weight loss drug supply woes

Good afternoon! All eyes are on Novo Nordisk and Eli Lilly again as Wall Street looks for signs that they can…

Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City,…

Symptoms from excessive screen time cost the U.S. $73 billion a year, study finds

American workers are spending too much time looking at screens. More than 104 million people in…

Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years

Artur Widak | Nurphoto | Getty Images Shares of Moderna closed more than 13% higher on…

AI, wearables and more — these markets are booming as the world ages. The pros share 4 stock picks

The world is aging rapidly, and there are more and more ways to invest in this…

The techno-optimists and doomsdayers inside Silicon Valley’s most dangerous AI debate

WASHINGTON, DC – SEPTEMBER 13: OpenAI CEO Sam Altman speaks with reporters on his arrival to…

Moderna, Merck vaccine with Keytruda cuts risk of deadly skin cancer returning in half, data says

An exterior view of Moderna’s clinical manufacturing facility.  David L. Ryan | Boston Globe | Getty…

Patients regain weight after stopping Eli Lilly’s Zepbound, study says

Eli Lilly’s drug tirzepatide was approved for weight loss by the FDA. Courtesy of Eli Lilly…

U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease

Blood sample tube with blood for Sickle Cell Screen -Test. Sickle cell blood test, abnormal hemoglobin…

U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients

At age 19, Joe Tsogbe underwent his first hip replacement. In his 20s, he averaged about…

Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops

Sopa Images | Lightrocket | Getty Images Pfizer’s twice-daily version of its experimental weight loss pill…

Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects

Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss…